
LQDA
Healthcare · Drug Manufacturers - Specialty & Generic · $5.17B market cap
$57.41-0.71 (-1.2%)Nov 13, 4:18 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -11.7% over 90 days · 30-day revisions 3 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | Before the open | 0.77 | 0.80 | +3.9% |
| Aug 12, 2026 | Before the open | 0.70 | -0.49 | -170.0% |
| May 11, 2026 | Before the open | 0.41 | 0.52 | +28.4% |
| Mar 12, 2026 | Time not confirmed | 0.19 | 0.15 | -22.0% |
| Nov 3, 2025 | Before the open | -0.35 | -0.04 | +88.6% |
| Aug 12, 2025 | Before the open | -0.39 | -0.49 | -25.6% |
| May 8, 2025 | Before the open | -0.42 | -0.45 | -7.1% |
| Mar 19, 2025 | Time not confirmed | -0.38 | -0.46 | -21.1% |
| Nov 13, 2024 | Before the open | -0.40 | -0.39 | +2.5% |
| Aug 7, 2024 | Before the open | -0.33 | -0.37 | -12.1% |
| May 13, 2024 | After the close | -0.32 | -0.54 | -68.8% |
| Mar 13, 2024 | Before the open | -0.23 | -0.42 | -82.6% |
| Nov 7, 2023 | Before the open | -0.19 |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also…
| -0.24 |
| -26.3% |
| Aug 10, 2023 | Before the open | -0.16 | -0.36 | -125.0% |
| May 4, 2023 | After the close | -0.17 | -0.15 | +11.8% |
| Mar 16, 2023 | Before the open | -0.15 | -0.09 | +40.0% |
| Nov 8, 2022 | After the close | -0.19 | -0.14 | +26.3% |
| Aug 11, 2022 | After the close | -0.22 | -0.15 | +31.8% |
| May 12, 2022 | After the close | -0.20 | -0.28 | -40.0% |
| Mar 17, 2022 | Before the open | -0.11 | -0.23 | -109.1% |
| Nov 3, 2021 | After the close | -0.15 | -0.14 | +6.7% |
| Aug 10, 2021 | After the close | -0.16 | -0.13 | +18.8% |
| May 13, 2021 | Before the open | -0.21 | -0.21 | 0.0% |
| Mar 22, 2021 | After the close | -0.36 | -0.38 | -5.6% |
| Nov 6, 2020 | After the close | -0.36 | -0.40 | -11.1% |
| Aug 10, 2020 | Before the open | -0.48 | -0.49 | -2.1% |
| May 11, 2020 | After the close | -0.55 | -0.52 | +5.5% |
| Mar 11, 2020 | Before the open | -0.59 | -0.71 | -20.3% |
| Nov 13, 2019 | After the close | -0.72 | -0.72 | 0.0% |
| Aug 8, 2019 | Before the open | -0.72 | -0.31 | +56.9% |
| May 2, 2019 | Before the open | -0.62 | -0.87 | -40.3% |
| Feb 26, 2019 | Before the open | -0.61 | -0.63 | -3.3% |
| Oct 31, 2018 | Before the open | -0.58 | -0.62 | -6.9% |
| Aug 14, 2018 | Before the open | -3.41 | -0.62 | +81.8% |
| Apr 11, 2018 | Time not confirmed | — | -1.85 | — |